chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037k20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Musculoskeletal stiffness, Swelling, Vaccination site pain
Clinical narrative: Hardness an pain on shoulder; swelling on the shoulder; Pain at the injection site; Chills; Joint and shoulder pain; This spontaneous case was reported by a non-health professional and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Hardness an pain on shoulder), SWELLING (swelling on the shoulder), VACCINATION SITE PAIN (Pain at the injection site), CHILLS (Chills) and ARTHRALGIA (Joint and shoulder pain) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Hardness an pain on shoulder), SWELLING (swelling on the shoulder), VACCINATION SITE PAIN (Pain at the injection site), CHILLS (Chills) and ARTHRALGIA (Joint and shoulder pain). On 19-Feb-2021, VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (Chills) had resolved, ARTHRALGIA (Joint and shoulder pain) had not resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Hardness an pain on shoulder) and SWELLING (swelling on the shoulder) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Email ID added. Non significant
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash
Clinical narrative: allergic reaction; Rash; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) and RASH (Rash) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (allergy to penicillin), Sulfonamide allergy (Allergic to sulfa drugs) and Allergy to antibiotic (Cipro allergy).    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction) and RASH (Rash). At the time of the report, HYPERSENSITIVITY (allergic reaction) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information, if any, was not provided by the reporter.  Treatment information, if any, was not provided.   This case was linked to MOD-2021-256597 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up received and Reporter information updated and new event added.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Very itchy; Rash at the injection site; Red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE ERYTHEMA (Red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATENOLOL, CITALOPRAM, OMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), AMITRIPTYLINE and OXYBUTYNIN for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Mass
Clinical narrative: Blister developed on her left hip; Lump on collar bone and chest area; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Lump on collar bone and chest area) and BLISTER (Blister developed on her left hip) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced MASS (Lump on collar bone and chest area). On 09-Feb-2021, the patient experienced BLISTER (Blister developed on her left hip). At the time of the report, MASS (Lump on collar bone and chest area) had resolved and BLISTER (Blister developed on her left hip) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (felt arm was a little sore in the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011ZLOA and 010M20A) for COVID-19 vaccination. Concurrent medical conditions included Atrium fibrilation (Atrium fibrilation) and Cholesterol. Concomitant products included METOPROLOL and APIXABAN (ELIQUIS) for Atrial fibrillation, SIMVASTATIN for Cholesterol, MINERALS NOS, VITAMINS NOS (ICAPS [MINERALS NOS;VITAMINS NOS]) for Eye disorder NOS, LUBIPROSTONE (AMITIZA), VITAMIN D [VITAMIN D NOS] and CALCIUM for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE PAIN (felt arm was a little sore in the injection site). On 11-Jan-2021, VACCINATION SITE PAIN (felt arm was a little sore in the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment information was not reported. This case was linked to MOD-2021-015964. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Followup received on 26-Apr-2021 content no new information
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: redness on the injection site arm; swelling on the injection site arm; a reaction that hurts to the touch on the injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness on the injection site arm), VACCINATION SITE SWELLING (swelling on the injection site arm) and VACCINATION SITE PAIN (a reaction that hurts to the touch on the injection site arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness on the injection site arm), VACCINATION SITE SWELLING (swelling on the injection site arm) and VACCINATION SITE PAIN (a reaction that hurts to the touch on the injection site arm). At the time of the report, VACCINATION SITE ERYTHEMA (redness on the injection site arm), VACCINATION SITE SWELLING (swelling on the injection site arm) and VACCINATION SITE PAIN (a reaction that hurts to the touch on the injection site arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was tender; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was tender) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (codeine and sulfa) and Penicillin allergy. Concomitant products included LOSARTAN and FAMOTIDINE (PEPCID AC) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was tender). At the time of the report, PAIN IN EXTREMITY (Arm was tender) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Tenderness
Clinical narrative: Tender Arm; Arm Stiffness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tender Arm) and MUSCULOSKELETAL STIFFNESS (Arm Stiffness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (Tender Arm) and MUSCULOSKELETAL STIFFNESS (Arm Stiffness). At the time of the report, TENDERNESS (Tender Arm) and MUSCULOSKELETAL STIFFNESS (Arm Stiffness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, COVID-19, Chills, Headache
Clinical narrative: tested positive for COVID-19 after receiving the vaccine; Fever 100.-100.3; Body Aches; Chills; Full blown head cold; Nasal Congestion; Very Weak; Worst Headache; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), COVID-19 (tested positive for COVID-19 after receiving the vaccine) and HEADACHE (Worst Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included MS (She has mild MS).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HEADACHE (Worst Headache). On 14-Feb-2021, the patient experienced NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), MYALGIA (Body Aches) and CHILLS (Chills). On 18-Feb-2021, the patient experienced PYREXIA (Fever 100.-100.3). On an unknown date, the patient experienced COVID-19 (tested positive for COVID-19 after receiving the vaccine). At the time of the report, NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), COVID-19 (tested positive for COVID-19 after receiving the vaccine), HEADACHE (Worst Headache), MYALGIA (Body Aches), CHILLS (Chills) and PYREXIA (Fever 100.-100.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: 100-100.3 °f (High) 100-100.3 °F. In 2021, SARS-CoV-2 test: positive (Positive) Covid positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly patient was taking unspecified mediation for MS (multiple sclerosis). The patient is unsure if COVID-19 is a side effect of the vaccine or if she contracted the virus at the facility where she went to receive the vaccine. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR: Patient tested positive for COVID-19 after receiving the vaccine
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Nasopharyngitis, Pyrexia, SARS-CoV-2 test
Clinical narrative: tested positive for COVID-19 after receiving the vaccine; Fever 100.-100.3; Body Aches; Chills; Full blown head cold; Nasal Congestion; Very Weak; Worst Headache; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), COVID-19 (tested positive for COVID-19 after receiving the vaccine) and HEADACHE (Worst Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included MS (She has mild MS).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HEADACHE (Worst Headache). On 14-Feb-2021, the patient experienced NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), MYALGIA (Body Aches) and CHILLS (Chills). On 18-Feb-2021, the patient experienced PYREXIA (Fever 100.-100.3). On an unknown date, the patient experienced COVID-19 (tested positive for COVID-19 after receiving the vaccine). At the time of the report, NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), COVID-19 (tested positive for COVID-19 after receiving the vaccine), HEADACHE (Worst Headache), MYALGIA (Body Aches), CHILLS (Chills) and PYREXIA (Fever 100.-100.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: 100-100.3 °f (High) 100-100.3 °F. In 2021, SARS-CoV-2 test: positive (Positive) Covid positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly patient was taking unspecified mediation for MS (multiple sclerosis). The patient is unsure if COVID-19 is a side effect of the vaccine or if she contracted the virus at the facility where she went to receive the vaccine. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR: Patient tested positive for COVID-19 after receiving the vaccine
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Fever; Fatigue; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 100.3 f (High) 100.3 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator Aleve used as a Treatment Medication.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Body temperature: 100 degrees f (High) Experienced a fever greater than 100 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine
Clinical narrative: Migraines; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraines) and HEADACHE (Headaches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraines) and HEADACHE (Headaches). At the time of the report, MIGRAINE (Migraines) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: sore arm; a little fatigue; OFF LABEL USE-under age; A spontaneous report () was received from a consumer concerning his daughter a 16-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events off label use-under age/product administered to patient of inappropriate age, sore arm/ pain in the extremity, fatigue.  The patient's medical history was not provided. Concomitant medications reported were none for drug use for unknown indication.  On 12 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 023M20A) Intramuscularly for prophylaxis of COVID-19 infection.  On  12 Mar 2021, the patient experienced the event(s) product administered to patient of inappropriate age. On an unknown date patient experienced  sore arm and a little fatigue.  Treatment details was not included  Action taken with mRNA-1273 in response to the events was not provided  The outcome of event(s), product administered to patient of inappropriate age was considered resolved on 12 Mar 2021. The outcome of the events sore arm and fatigue were unknown; Reporter's Comments: This report refers to a case of 16- year-old female patient received Moderna's COVID-19 vaccine (Inappropriate age at vaccine administration) for mRNA-1273, 023M20A. and experienced sore arm and fatigue.  Based on a temporal association between the events of sore arm and fatigue and use of the product, a causal relationship cannot be excluded. The event of inappropriate age at vaccine administration is assessed as not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Soreness in arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Soreness in arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient said that maybe took aspirin but doesn't remember.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Musculoskeletal stiffness, Peripheral swelling, Pruritus, Rash erythematous
Clinical narrative: Discomfort; Hard; swollen; red, 3 to 4 inches, Slight redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Hard), PERIPHERAL SWELLING (swollen), RASH ERYTHEMATOUS (red, 3 to 4 inches, Slight redness), PRURITUS (itching) and DISCOMFORT (Discomfort) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Hard), PERIPHERAL SWELLING (swollen), RASH ERYTHEMATOUS (red, 3 to 4 inches, Slight redness) and PRURITUS (itching). On an unknown date, the patient experienced DISCOMFORT (Discomfort). At the time of the report, MUSCULOSKELETAL STIFFNESS (Hard), PERIPHERAL SWELLING (swollen), RASH ERYTHEMATOUS (red, 3 to 4 inches, Slight redness), PRURITUS (itching) and DISCOMFORT (Discomfort) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Benadryl and ice used as Treatment medication. No Concomitant medication was provided by Reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Dyspnoea, Pain in extremity, Vaccination site erythema
Clinical narrative: Arm was sore including the armpit; Shortness of breath when lying down; Arm was sore including the armpit; Redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on the injection site). On 04-Feb-2021, VACCINATION SITE ERYTHEMA (Redness on the injection site) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Reporter did not allow further contact
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site cellulitis, Vaccination site erythema, Vaccination site swelling
Clinical narrative: it's like cellulitis; swollen and it feels warm to the touch; swollen and it feels warm to the touch; It's red; feels like a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Cellulitis.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever). At the time of the report, VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 36.2 degree Celsius (Inconclusive) 36.2C.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol used as a Treatment Medication. No concomitant Medication was Provided.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: it's like cellulitis; swollen and it feels warm to the touch; swollen and it feels warm to the touch; It's red; feels like a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Cellulitis.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever). At the time of the report, VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 36.2 degree Celsius (Inconclusive) 36.2C.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol used as a Treatment Medication. No concomitant Medication was Provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Tender arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. Concomitant products included CHOLESTEROL and THYROID THERAPY. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Tender arm). On 28-Jan-2021, PAIN IN EXTREMITY (Tender arm) had resolved. This case was linked to US-MODERNATX, INC.-MOD-2021-022449 (E2B Linked Report). This case was linked to MOD-2021-163880, MOD-2021-163880. Reporter did not allow further contact. Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: TCR; Sender's Comments: US-MODERNATX, INC.-MOD-2021-022449:Crosslinked (MOD21-020670)
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Herpes zoster, Pruritus, Rash
Clinical narrative: Itching all over my body; Looked a lot like shingles; Bad rash on my face; Fatigue; Headache; Arm was very sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over my body), HERPES ZOSTER (Looked a lot like shingles), RASH (Bad rash on my face), FATIGUE (Fatigue) and HEADACHE (Headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Arm was very sore at the injection site). On 02-Feb-2021, the patient experienced PRURITUS (Itching all over my body), HERPES ZOSTER (Looked a lot like shingles) and RASH (Bad rash on my face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching all over my body), HERPES ZOSTER (Looked a lot like shingles), RASH (Bad rash on my face), FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Arm was very sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Non significant follow up received on 04-MAY-2021, no new information
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Itching all over my body; Looked a lot like shingles; Bad rash on my face; Fatigue; Headache; Arm was very sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over my body), HERPES ZOSTER (Looked a lot like shingles), RASH (Bad rash on my face), FATIGUE (Fatigue) and HEADACHE (Headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Arm was very sore at the injection site). On 02-Feb-2021, the patient experienced PRURITUS (Itching all over my body), HERPES ZOSTER (Looked a lot like shingles) and RASH (Bad rash on my face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching all over my body), HERPES ZOSTER (Looked a lot like shingles), RASH (Bad rash on my face), FATIGUE (Fatigue), HEADACHE (Headache) and VACCINATION SITE PAIN (Arm was very sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Non significant follow up received on 04-MAY-2021, no new information
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. Not Provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching arm; Place around the injection is red; Diameter of 3-4 inches around - swollen; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), VACCINATION SITE PRURITUS (Itching arm), VACCINATION SITE ERYTHEMA (Place around the injection is red) and VACCINATION SITE SWELLING (Diameter of 3-4 inches around - swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching arm), VACCINATION SITE ERYTHEMA (Place around the injection is red) and VACCINATION SITE SWELLING (Diameter of 3-4 inches around - swollen). At the time of the report, PAIN IN EXTREMITY (Arm was sore), VACCINATION SITE PRURITUS (Itching arm), VACCINATION SITE ERYTHEMA (Place around the injection is red) and VACCINATION SITE SWELLING (Diameter of 3-4 inches around - swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain
Clinical narrative: Arm is hurting all night; Swollen a little bit; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Arm is hurting all night) and PERIPHERAL SWELLING (Swollen a little bit) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is hurting all night) and PERIPHERAL SWELLING (Swollen a little bit). At the time of the report, VACCINATION SITE PAIN (Arm is hurting all night) and PERIPHERAL SWELLING (Swollen a little bit) was resolving. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient mentioned unspecified diabetic medications as concomitant medications. No treatment medications were reported.  Follow-up document received on 12 Jul 2021 contains information as patient is feeling okay.   .   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up document received, updated event outcome details.
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Cough, Fatigue, Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), RHINORRHOEA (runny nose), AXILLARY PAIN (arm pain) and FATIGUE (fatigue) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History was provided by the reporter.  On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced COUGH (Cough), RHINORRHOEA (runny nose), AXILLARY PAIN (arm pain) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COUGH (Cough), RHINORRHOEA (runny nose), AXILLARY PAIN (arm pain) and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain) and NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm Pain) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Arm Pain) and NAUSEA (Nausea) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were provided by reporter. Reporter did not allow further contact.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Pyrexia
Clinical narrative: Fever; Headache; Weakness; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), FATIGUE (Very tired), PYREXIA (Fever) and HEADACHE (Headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.     On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ASTHENIA (Weakness) and FATIGUE (Very tired). On 18-Feb-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, ASTHENIA (Weakness), FATIGUE (Very tired), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were provided by reporter  Treatment details was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash macular, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Arm has a red big blotch about 4 inches tall and 6 inches wide/Started small quickly grew to 4inch by 6inch patch; Itching; Redness and swelling on left upper arm site of injection; Redness and swelling on left upper arm site of injection; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Arm has a red big blotch about 4 inches tall and 6 inches wide/Started small quickly grew to 4inch by 6inch patch), PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness and swelling on left upper arm site of injection) and VACCINATION SITE SWELLING (Redness and swelling on left upper arm site of injection) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism, GERD and Vitamin D deficiency. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for GERD, LEVOTHYROXINE and LIOTHYRONINE for Hypothyroidism, VITAMIN D2 for Vitamin D deficiency, HYDROCHLOROTHIAZIDE, IRBESARTAN (IRBESARTAN HCTZ) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced RASH MACULAR (Arm has a red big blotch about 4 inches tall and 6 inches wide/Started small quickly grew to 4inch by 6inch patch), PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness and swelling on left upper arm site of injection) and VACCINATION SITE SWELLING (Redness and swelling on left upper arm site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) (topical) for Adverse event, at a dose of 1 dosage form and BACITRACIN, POLYMYXIN B SULFATE (POLYSPORIN [BACITRACIN;POLYMYXIN B SULFATE]) (topical) for Adverse event, at a dose of 1 dosage form. At the time of the report, RASH MACULAR (Arm has a red big blotch about 4 inches tall and 6 inches wide/Started small quickly grew to 4inch by 6inch patch), PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness and swelling on left upper arm site of injection) and VACCINATION SITE SWELLING (Redness and swelling on left upper arm site of injection) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.           Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Major update in Narrative, Med.History, Action Taken, Con.Meds, Treatment, Events &  Event Assessment  Treatment included Benadryl- A and polysporin.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Musculoskeletal stiffness, Swelling
Clinical narrative: muscle stiffness around injection site; redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (muscle stiffness around injection site), ERYTHEMA (redness) and SWELLING (Swelling) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (muscle stiffness around injection site), ERYTHEMA (redness) and SWELLING (Swelling). At the time of the report, MUSCULOSKELETAL STIFFNESS (muscle stiffness around injection site), ERYTHEMA (redness) and SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter  Treatment for the events is Unknown.    Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: both feet are itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (both feet are itchy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LOVASTATIN for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (both feet are itchy). At the time of the report, PRURITUS (both feet are itchy) outcome was unknown.            Treatment details included diphenhydramine.   Reporter did not allow further contact
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchy; Swelling/ Raised up; Redness; A spontaneous report was received from a consumer concerning a 56-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events swelling,raised up/ vaccination site swelling, redness/ vaccination site erythema, itchy/ vaccination site pruritus.  The patient's medical history was not provided. Concomitant medications reported were diabetes medication and high blood pressure medication(not specified).  On 9 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events swelling, redness, itchy and raised up at the injection site.  No treatment was taken.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events swelling, redness, itchy and raised up were unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Illness
Clinical narrative: Mild symptoms/ Covid 19; A little sick; A spontaneous report was received from a consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  mild symptoms/Covid 19, a little sick/ illness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 18 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced mild symptoms, and a little sick.She did not get tested for Covid but she stated that she knew that was what she had.No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  On Feb 2021 the outcome of events mild symptoms, covid-19, a little sick was resolved.